Abstract
Breakdown of the blood brain barrier and the subsequent accumulation of free radicals, lactate, and glutamate appear to be the immediate causes of thiamine deficiency (TD)-induced damage to thalamus. The mechanisms triggering these events are unknown but recent evidence suggests an important role of histamine. We therefore studied the effects of histamine depletion on thalamic lesions in the pyrithiamine-induced thiamine deficient (PTD) rat. Chronic intracerebroventricular (i.c.v., 7 days) infusion of α-fluoromethylhistidine (FMH), combined with bilateral ibotenate destruction of the histamine-containing neurons in the tuberomammillary (TM) nucleus and bolus i.c.v. infusion of 48/80, a potent mast cell degranulating agent, was used to deplete brain histamine levels. PTD rats receiving combined FMH + 48/80 + TM lesions developed acute neurological symptoms, including spontaneous seizures, approximately 1 day earlier than PTD rats treated with i.c.v. infusion of vehicle and sham lesions of the TM. When examined 1 week after restoration of thiamine, the PTD vehicle + sham lesion animals contained severe neuronal loss and gliosis in midline, intralaminar, ventral, lateral, and posterior nuclei. PTD animals treated with FMH + 48/80 + TM lesions had little evidence of neuronal loss or microglial proliferation in thalamus except in the gelatinosus and anteroventral nuclei, in which there was complete neuronal loss. These data demonstrate a significant and regionally selective role of histamine in the development of thalamic lesions in a rat model of Wernicke's encephalopathy. Furthermore, these data suggest either a dissociation between seizures and thalamic lesions or a significant role of histamine in seizure-related damage to the thalamus.
Similar content being viewed by others
REFERENCES
Abbott, N.J. (2000). Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20:131-147.
Blass, J.P. (1979). Disorders of pyruvate metabolism. Neurology 29:280-286.
Bugajski, A.J., Chlap, Z., Gadek-Michalska, A., Borycz, J., and Bugajski, J. (1997). Effect of compound 48/80 on mast cells and histamine levels in rat brain and on corticosterone secretion. Inflamm. Res. 46(Suppl. 1): S47-S48.
Calingasan, N.Y., Baker, H., Sheu, K.-F.R., and Gibson, G.E. (1995). Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp. Neurol. 134:64-72.
Calingasan, N.Y., Park, L.C.H., Callo, L.L., Trifiletti, R.R., Gandy, S.E., and Gibson, G.E. (1998). Induction of nitric oxide synthase and microglial responses precede selective cell death induced by impairment of oxidative metabolism. Am. J. Pathol. 153:599-610.
Colwell, C.S., and Levine, M.S. (1997). Histamine modulates NMDA-mediated swelling in the neostriatum. Brain Res. 766:205-212.
De Reuck, J.L., Sieben, G.J., Sieben-Praet, M.R., Ngendahayo, P., De Coster, W.J.P., and Vander Eecken, H.M. (1980). Wernicke's encephalopathy in patients with tumors of the lymphoid-hemopoietic systems. Arch. Neurol. 37:338-341.
Ferguson, M., Dalve-Endres, A.M., McRee, R.C., and Langlais, P.J. (1999). Increased mast cell degranulation within thalamus in early pre-lesion stages of an experimental model of Wernicke's encephalopathy. J. Neuropathol. Exp. Neurol. 58:773-783.
Foresti, V., Parisio, E., Scolari, N., Sparacio, F., and Confalonieri, F. (1986). Sindrome da immunodefizienza acquisita associata a tuberculosi disseminata ed a encefalopatia cronica di Wernicke. Recenti Prog. Med. 77:350-352.
Galli, S.J. (1993). New concepts about the mast cell. N. Engl. J. Med. 328:257-265.
Glowinski, J., and Iversen, L.L. (1966). Regional studies of catecholamines in the rat brain. I. The disposition of tritiated norepinephrine, dopamine and dopa in various regions of the brain. J. Neurochem. 13:655-669.
Goldschmidt, R.C., Hough, L.B., Glick, S.D., and Padawer, J. (1984). Mast cells in rat thalamus: Nuclear localization, sex differences, and left-right asymmetry. Brain Res. 323:209-217.
Hakim, A.M. (1984). The induction and reversibility of cerebral acidosis in thiamine deficiency. Ann. Neurol. 16:673-679.
Hakim, A.M. (1986). Effect of thiamine deficiency and its reversal on cerebral blood flow in the rat. Observations on the phenomena of hyperperfusion, “no reflow” and delayed hypoperfusion. J. Cereb. Blood Flow Metab. 6:79-85.
Harata, N., and Iwasaki, Y. (1995). Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse. Metab. Brain Dis. 10:159-174.
Harper, C.G., Giles, M., and Finaly-Jones, R. (1986). Clinical signs in the Wernicke-Korsakoff complex-a retrospective analysis of 131 cases diagnosed at autopsy. J. Neurol. Neurosurg. Psychiatry 49:341-345.
Hough, L.B. (1999). Histamine. In (G. Siegel, B. Agranoff, R. Albers, S. Fisher, and M. Uhler, eds.), Basic Neurochemistry, Lippincott-Raven, New York, pp. 293-313.
Jellinger, K., and Seitelberger, F. (1970). Subacute necrotizing encephalomyelopathy. In (I. Mehilmeyer, A.F. Muller, A. Prader, and R. Schoen, eds.), Ergebuisse Der Innerren Medizin und Kinderkeikunde, Springer, Berlin-Heidelberg, pp. 155-219.
Langlais, P.J., Anderson, G., Guo, S.-X., and Bondy, S.C. (1997). Increased cerebral free radical production during thiamine deficiency. Metab. Brain Dis. 12:137-143.
Langlais, P.J., Anderson, G., Powell, H., and Dimlich, R. (1999). Mast cell degranulation and edematous changes in pre-necrotic stages of a rat model of Wernicke's encephalopathy. Brain Pathol. 7:1020.
Langlais, P.J., and Mair, R.G. (1990). Protective effects of the glutamate antagonist MK-801 on pyrithiamine induced lesions and amino acid changes in rat brain. J. Neurosci. 10:1664-1674.
Langlais, P.J., and Zhang, S.-X. (1993). Extracellular glutamate is increased in thalamus during thiamine deficiencyinduced lesions and is blocked by MK-801. J. Neurochem. 61:1155-1158.
Langlais, P.J., Zhang, S.X., Weilersbacher, G., Hough, L.B., and Barke, K.E. (1994). Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy. J. Neurosci. Res. 38:564-565.
Lindboe, C.F., and Loberg, E.M. (1988). The frequency of brain lesions in alcoholics. J. Neurol. Sci. 88:107-113.
Lopez, R.I., and Collins, G.H. (1968).Wernicke's encephalopathy: A complication of chronic hemodialysis. Arch. Neurol. 18:248-259.
McRee, R.C., Terry-Ferguson, M., Langlais, P.J., Chen, Y., Nalwalk, J.W., Blumenstock, F.A., and Hough, L.B. (2000). Increased histamine release and granulocytes within the thalamus of a rat model of Wernicke's encephalopathy. Brain Res. 858:227-236.
Nightingale, S., Bates, D., Heath, P.D., and Barron, F. (1982). Wernicke's encephalopathy in hyperemesis gravidarum. Postgrad. Med. J. 58:558-559.
Okayama, Y., Bradding, P., Tunon-de-Lara, J.M., Holgate, S.T., and Church, M.K. (1993). Cytokine production by human mast cells. In (G. Marone, ed.), Human Basophils and Mast cells: Biological Aspects, Vol. 61, Karger, New York, pp. 114-134.
Omer, S.M., Kawi, M.Z., Watban, J., Bohlega, S., McLean, D.R., and Miller, G. (1995). Acute Wernicke's encephalopathy associated with hyperemesis gravidarum: Magnetic resonance findings. J. Neuroimaging 5:251-253.
Onodera, K., Maeyama, K., and Watanabe, T. (1988). Regional changes in brain histamine levels following dietary-induced thiamine deficiency in rats. Jpn. J. Pharmacol. 47:323-326.
Onodera, K., Shinoda, H., and Watanabe, T. (1990). Effects of thiamine on hypothermia and hypothalamic histamine levels in dietary-induced thiamine deficient rats. Jpn. J. Pharmacol. 54:339-343.
O'Rourke, N.P., Bunker, V.W., Thomas, A.J., Finglas, P.M., Bailey, A.L., and Clayton, B.E. (1990). Thiamine status of healthy and institutionalized elderly subjects: Analysis of dietary intake and biochemical indices. Age Ageing 19:325-329.
Palacios, J.M., Wamsley, J.K., and Kuhar, M.J. (1981). The distribution of H,-receptors in the rat brain: An autographic study. Neuroscience 6:15-37.
Panula, P., Airaksinen, M.S., Pirvola, U., and Kotilainen, E. (1990). A histamine-containing neuronal system in human brain. Science 34:127-132.
Pitella, J.E.H., and de Castro, L.P.F. (1990). Wernicke's encephalopathy manifested as Korsakoff syndrome in a patient with promyelocytic leukemia. South. Med. J. 83:570-573.
Purcell, W.M., and Atterwill, C.K. (1995). Mast cells in neuroimmune function: Neurotoxicological and neuropharmacological perspectives. Neurochem. Res. 20:521-532.
Schwenk, J., Gosztonyi, G., Thierauf, P., Iglesias, J., and Langer, E. (1990). Wernicke's encephalopathy in two patients with acquired immunodeficiency syndrome. J. Neurol. 237:445-447.
Shelton, M.K., and McCarthy, K.D. (2000). Hippocampal astrocytes exhibit Ca++-elevating muscarinic, cholinergic and histaminergic receptors in situ. J. Neurochem. 74:555-563.
Skratt, J.J., Hough, L.B., Nalwalk, J.W., and Barke, K.E. (1994). alpha-Fluoromethylhistidine-induced inhibition of brain histidine decarboxylase. Implications for the CO2-trapping enzymatic method. Biochem. Pharmacol. 47:397-402.
Steinbusch, H.M., and Verhofstad, A.J. (1986). Immunocytochemical demonstration of noradrenaline, serotonin and histamine and some observations of the innervations of the intracerebral blood vessels. In (C. Owman and J.E. Hardebo, eds.), Neural Regulation of Brain Circulation, Elsevier, Amsterdam, Holland, pp. 181-194.
Tagaki, H. Moroshima, T., Matsuyama, T., Hayashi, H., Watanabe, T., and Wada, H. (1986). Histaminergic axons in the neostriatum and cerebral cortex of the ratio correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a Marker. Brain Research 364:114-123.
Todd, K.G., and Butterworth, R.F. (1998). Evaluation of the role ofNMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy. Exp. Neurol. 149:130-138.
Verburg, K.M., Bowsher, R.R., and Henry, D.P. (1983). A new radioenzymatic assay for histamine using purified histamine-N-methyltransferase. Life Sci. 32:2855-2867.
Victor, M., Adams, R.D., and Collins, G.H. (1989). The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition, Davis, Philadelphia, Pennsylvania.
Watanabe, I., and Kanabe, S. (1978). Early edematous lesion of pyrithiamine-induced acute thiamine-deficient encephalopathy in the mouse. J. Neuropathol. Exp. Neurol. 37:401-413.
Watanabe, T., Yamatodani, A., Maeyama, K., and Wada, H. (1990). Pharmacology of ?-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase. TIPS 11:363-367. Yokohama, H., Onodera, K.,Maeyama, K.,Yanai, K., Iinuma, K.,Tuomisto, L., andWatanabe,T. (1992). Histamine levels and clonic convulsions of electrically-induced seizure in mice: The effects of ?-fluoromethylhistidine and metoprine. N.-S. Arch. Pharmacol. 346:4-45.
Zhang, S.-X., Weilersbacher, G.S., Henderson, S.W., Corso, T., Olney, J.W., and Langlais, P.J. (1995). Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions. J. Neuropathol. Exp. Neurol. 54:255-267.
Rights and permissions
About this article
Cite this article
Langlais, P.J., McRee, R.C., Nalwalk, J.A. et al. Depletion of Brain Histamine Produces Regionally Selective Protection against Thiamine Deficiency-Induced Lesions in the Rat. Metab Brain Dis 17, 199–210 (2002). https://doi.org/10.1023/A:1019930206196
Issue Date:
DOI: https://doi.org/10.1023/A:1019930206196